DBA/2J is an inbred mouse strain widely used in hearing research, as it
displays progressive hair cell loss and degeneration of spiral ganglion neurons
(SGNs) characterized by early-onset progressive hearing loss (ePHL). Mouse nerve
growth factor (mNGF), as a common exogenous nerve growth factor (NGF), has been
studied extensively for its ability to promote neuronal survival and growth. To
determine whether mNGF can ameliorate progressive hearing loss (PHL) in DBA/2J
mice, saline or mNGF was given to DBA/2J mice of either sex by daily
intramuscular injection from the 1st to the 9th week after birth. At 5, 7, and 9
weeks of age, in comparison with vehicle groups, mNGF groups experienced
decreased auditory-evoked brainstem response (ABR) thresholds and increased
distortion product otoacoustic emission (DPOAE) amplitudes, the prevention of
hair cell loss, and the inhibition of apoptosis of SGNs. Downregulation of
Bak/Bax and Caspase genes
and proteins in cochleae of mice receiving the mNGF treatment was detected by
Real-time PCR, Western Blot and Immunohistochemistry. This suggests that the
Bak-dependent mitochondrial apoptosis pathway may be involved in the
otoprotective mechanism of mNGF in progressive hearing loss of DBA/2J mice. Our
results demonstrate that mNGF can act as an otoprotectant in the DBA/2J mice for
the early intervention of PHL and, thus, could become of great value in clinical
applications.